Basic fibroblast growth factor augments podocyte injury and induces glomerulosclerosis in rats with experimental membranous nephropathy

Journal of Clinical Investigation

Volumn 96, Issue 6, 1995, Pages 2809-2819

  Floege, Jürgen ^a   Kriz, Wilhelm ^b   Schulze, Matthias ^a   Susani, Martin ^c   Kerjaschki, Dontscho ^c   Mooney, Andrew ^e   Couser, William G ^d   Koch, Karl M ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF VIENNA   (Austria)

^d UNIVERSITY OF WASHINGTON   (United States)

^e NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

epithelial cells; FGF receptor; glomerulonephritis; growth factor; HIV nephropathy

Indexed keywords

ANTIBODY; BASIC FIBROBLAST GROWTH FACTOR; COMPLEMENT; DESMIN; FIBROBLAST GROWTH FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; COMPLEMENT DEPOSITION; CONTROLLED STUDY; GENE EXPRESSION; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION; HEYMANN NEPHRITIS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MEMBRANOUS GLOMERULONEPHRITIS; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEINURIA; RAT; RECEPTOR UPREGULATION;

EID: 0028817922     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118351     Document Type: Article

References (47)

1. Couser, W. G., and C. K. Abrass. 1988. Pathogenesis of membranous nephropathy. Annu. Rev. Med. 39:517-530.
2. Kerjaschki, D. 1990. The pathogenesis of membranous glomerulonephritis: from morphology to molecules. Virchows Arch. B Cell Pathol. 58:253-271.
3. Floege, J., E. Eng, V. Lindner, B. A. Young, M. A. Reidy, and R. J. Johnson. 1992. Rat glomerular mesangial cells synthesize basic FGF: release, upregulated synthesis, and mitogenicity in mesangial proliferative glomerulonephritis. J. Clin. Invest. 90:2362-2369.
4. Floege, J., E. Eng, B. A. Young, and R. J. Johnson. 1993. Factors involved in the regulation of glomerular mesangial cell proliferation in vitro and in vivo. Kidney Int. 43:S47-S54.
5. Klagsbrunn, M., and E. R. Edelman. 1989. Biological and biochemical properties of fibroblast growth factors. Implications for the pathogenesis of atherosclerosis. Arteriosclerosis 9:269-278.
6. D'Amore, P. A. 1990. Modes for FGF release in vivo and in vitro. Cancer Metastasis Rev. 9:227-238.
7. Takeuchi, A., N. Yoshizawa, M. Yamamoto, Y. Sawasaki, T. Oda, A. Senoo, H. Niwa, and Y. Fuse. 1992. Basic fibroblast growth factor promotes proliferation of rat glomerular visceral epithelial cells in vitro. Am. J. Pathol. 141:107-116.
8. Silver, B. J., F. E. Jaffer, and H. E. Abboud. 1988. Platelet-derived growth factor synthesis in mesangial cells: induction by multiple peptide mitogens. Proc. Natl. Acad. Sci. USA. 86:1056-1060.
9. Alousi, M. A., R. S. Post, and W. Heymann. 1969. Experimental autoimmune nephrosis in rats. Am. J. Pathol. 54:47-71.
10. Salant, D. J., C. Darby, and W. G. Couser. 1980. Experimental membranous glomerulonephritis in rats. Quantitative studies of glomerular immune deposit formation in isolated glomeruli and whole animals. J. Clin. Invest. 66:71-81.
11. Schulze, M., P. J. Baker, D. T. Perkinson, R. J. Johnson, R. F. Ochi, R. A. K. Stahl, and W. G. Couser. 1989. Urinary excretion of C5b-9 distinguishes passive Heymann nephritis from other forms of experimental glomerulonephritis in the rat. Kidney Int. 35:60-68.
12. Johnson, R. J., P. Pritzl, H. Iida, and C. E. Alpers. 1991. Platelet-complement interactions in mesangial proliferative nephritis in the rat. Am. J. Pathol. 138:313-321.
13. Susani, M., M. Schulze, M. Exner, and D. Kerjaschki. 1994. Antibodies to glycolipids activate complement and promote proteinuria in passive Heymann nephritis. Am. J. Pathol. 144:807-819.
14. Johnson, R. J., R. L. Garcia, P. Pritzl, and C. E. Alpers. 1990. Platelets mediate glomerular cell proliferation in immune complex nephritis induced by anti-mesangial cell antibodies in the rat. Am. J. Pathol. 136:369-374.
15. Baker, A. J., A. Mooney, J. Hughes, D. Lombardi, R. J. Johnson, and J. Savill. 1994. Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J. Clin. Invest. 94:2105-2116.
16. Floege, J., M. W. Burns, C. E. Alpers, A. Yoshimura, P. Pritzl, K. Gordon, R. A. Seifert, D. F. Bowen-Pope, W. G. Couser, and R. J. Johnson. 1992. Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. Kidney Int. 41:297-309.
17. Dijkstra, C. D., E. A. Dopp, P. Joling, and G. Kraal. 1985. The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage populations in the rat recognized by monoclonal antibodies ED1, ED2, and ED3. Immunology. 54:589-599.
18. Sekiya, S., S. Gotoh, T. Yamashita, T. Watanabe, S. Saitoh, and F. Sendo. 1989. Selective depletion of rat neutrophils by in vivo administration of a monoclonal antibody. J. Leukocyte Biol. 46:96-102.
19. Reilly, T. M., D. S. Taylor, W. F. Herblin, M. J. Thoolen, A. T. Chiu, D. W. Watson, and P. B. M. W. M. Timmermans. 1989. Monoclonal antibodies directed against basic fibroblast growth factor which inhibit its biological activity in vitro and in vivo. Biochem. Biophys. Res. Commun. 2:736-743.
20. Floege, J., R. J. Johnson, K. Gordon, H. Iida, P. Pritzl, A. Yoshimura, C. Campbell, C. E. Alpers, and W. G. Couser. 1991. Increased synthesis of extracellular matrix in mesangial proliferative nephritis. Kidney Int. 40:477-488.
21. Adler, S., L. J. Striker, G. E. Striker, D. T. Perkinson, J. Hibbert, and W. G. Couser. 1986. Studies of progressive glomerular sclerosis in the rat. Am. J. Pathol. 123:553-562.
22. Weise, B., T. Janet, and C. Grothe. 1993. Localization of bFGF and FGF-receptor in the developing nervous system of the embryonic and newborn rat. J. Neurosci. Res. 34:442-453.
23. Kerjaschki, D., M. Schulze, S. Binder, R. Kain, P. P. Ojha, M. Susani, R. Horvat, P. J. Baker, and W. G. Couser. 1989. Transcellular transport and membrane insertion of the C5b-9 membrane attack complex of complement by glomerular epithelial cells in experimental membranous nephropathy. J. Immunol. 143:546-552.
24. Johnson, R. J., H. Iida, C. E. Alpers, M. W. Majesky, S. M. Schwartz, P. Pritzl, K. Gordon, and A. M. Gown. 1991. Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. J. Clin. Invest. 87:847-858.
25. Wallenstein, S., C. L. Zucker, and J. L. Fleiss. 1980. Some statistical methods useful in circulation research. Circ. Res. 47:1-9.
26. Floege, J., C. E. Alpers, E. H. Sage, P. Pritzl, K. Gordon, R J. Johnson, and W. G. Couser. 1992. Markers of complement dependent and complement independent glomerular visceral epithelial cell injury in vivo. Lab. Invest. 67:486-497.
27. Floege, J., R. J. Johnson, K. Gordon, A. Yoshimura, C. Campbell, L. Iruela-Arispe, C. E. Alpers, and W. G. Couser. 1992. Altered glomerular extracellular matrix synthesis in experimental membranous nephropathy. Kidney Int. 42:573-585.
28. Floege, J., C. E. Alpers, M. W. Burns, P. Pritzl, K. Gordon, W. G. Couser, and R. J. Johnson. 1992. Glomerular cells, extracellular matrix accumulation, and the development of glomerulosclerosis in the remnant kidney model. Lab Invest. 66:485-497.
29. Yaoita, E., K. Kawasaki, T. Yamamoto, and I. Kihara. 1990. Variable expression of desmin in rat glomerular epithelial cells. Am. J. Pathol. 136:899-908.
30. Floege, J., R. J. Johnson, C. E. Alpers, C. A. Richardson, K. Gordon, and W. G. Couser. 1993. Visceral glomerular epithelial cells can proliferate in vivo and synthesize PDGF B-chain. Am. J. Pathol. 142:637-650.
31. Kriz, W., B. Hähnel, S. Rösener, and M. Elger. 1995. Long term treatment of rats with FGF-2 results in focal segmental glomerulosclerosis. Kidney Int. In press.
32. Kanwar, Y. S., Z. Z. Liu, N. Kashihara, and E. I. Wallner. 1991. Current status of the structure and functional basis of glomerular filtration and proteinuria. Semin. Nephrol. 11:390-413.
33. Firth, J. D. 1990. Effect of polycations on the function of the isolated perfused rat kidney. Clin. Sci. 79:591-598.
34. Zoja, C., D. Corna, T. Bertani, and G. Remuzzi. 1992. Rats with passive Heymann nephritis and long-lasting proteinuria develop focal segmental glomerulosclerosis. J. Am. Soc. Nephrol. 3:624a. (Abstr.)
35. Kriz, W., M. Elger, M. Nagata, M. Kretzler, S. Uiker, I. Koeppen-Hagemann, S. Tenschert, and K. V. Lemley. 1994. The role of podocytes in the development of glomerular sclerosis. Kidney Int. 45:S64-S72.
36. Lindner, V., R. A. Majack, and M. A. Reidy. 1991. Basic fibroblast growth factor mediates endothelial regrowth and proliferation in denuded arteries. J. Clin. Invest. 85:2004-2008.
37. Jeraj, K., R. L. Vernier, S. P. Sisson, and A. F. Michael. 1984. A new glomerular antigen in passive Heymann's nephritis. Br. J. Exp. Pathol. 65:485-498.
38. Hughes, S. E., and P. A. Hall. 1993. Immunolocalization of fibroblast growth factor receptor-1 and its ligands in human tissues. Lab. Invest. 69:173-182.
39. Jyo, Y., T. Sasaki, H. Tamai, T. Nohno, N. Itoh, and G. Osawa. 1994. Demonstration of fibroblast growth factor receptor mRNA in glomeruli in mesangial proliferative nephritis by in situ hybridization. J. Am. Soc. Nephrol. 5:784a. (Abstr.)
40. Camussi, G., D. Kerjaschki, M. Gonda, T. Nevins, J. C. Rielee, J. Brent-jens, and G. Andres. 1989. Expression and modulation of surface antigens in cultured rat glomerular visceral epithelial cells. J. Histochem. Cytochem. 37:1675-1687.
41. Kerjaschki, D., and M. G. Farquhar. 1983. Immunocytochemical localization of the Heymann nephritis antigen (gp 330) in glomerular epithelial cells of normal Lewis rats. J. Exp. Med. 157:667-686.
42. Rapraeger, A. C., A. Krufka, and B. B. Olwin. 1991. Requirement of heparan sulphate for bFGF-mediated fibroblast growth and myoblast differentiation. Science (Wash. DC). 252:1705-1708.
43. Mazue, G., F. Bertolero, L. Garofano, M. Brughera, and P. Carminati. 1992. Experience with the preclinical assessment of basic fibroblast growth factor. Toxicol. Lett. (Amst.). 64-65 Spec No: 329-328.
44. Benzaquen, L. R., A. Nicholson-Weller, and J. A. Halperin. 1994. Terminal complement proteins C5b-9 release basic fibroblast growth factor and platelet-derived growth factor from endothelial cells. J. Exp. Med. 179:985-992.
45. Rao, T. K. S. 1991. Human immunodeficiency virus (HIV) associated nephropathy. Annu. Rev. Med. 42:391-401.
46. Ray, P. E., L. A. Bruggeman, B. S. Weeks, J. B. Kopp, J. L. Bryant, J. W. Owens, A. L. Notkins, and P. E. Klotman. 1994. bFGF and its low affinity receptors in the pathogenesis of HIV-associated nephropathy in transgenic mice. Kidney Int. 46:759-772.
47. Detwiler, R. K., R. J. Falk, S. L. Hogan, and J. C. Jennette. 1994. Collapsing glomerulopathy: a clinically and pathologically distinct variant of focal segmental glomerulosclerosis. Kidney Int. 45:1416-1424.